Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia AML”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchNot Yet RecruitingNCT06702098
What this trial is testing

Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Guangzhou Ruixin Biotechnological Co., LTD 10
Testing effectiveness (Phase 2)UnknownNCT04809181
What this trial is testing

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

Who this might be right for
Hematologic MalignancyStem Cell Transplant Complications
First Affiliated Hospital of Zhejiang University 95
Testing effectiveness (Phase 2)Study completedNCT00106600
What this trial is testing

Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous Leukemia
CTI BioPharma 12
Large-scale testing (Phase 3)Looking for participantsNCT05429632
What this trial is testing

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Who this might be right for
Adult Acute Myeloid Leukemia
Priothera SAS 366
Early research (Phase 1)Study completedNCT00009698
What this trial is testing

Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 1
Early research (Phase 1)Ended earlyNCT02049801
What this trial is testing

MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+12 more
Bruno C. Medeiros 1
Early research (Phase 1)Study completedNCT05665530
What this trial is testing

PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

Who this might be right for
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Mantle Cell Lymphoma (MCL)+9 more
Prelude Therapeutics Incorporated 86
Large-scale testing (Phase 3)Looking for participantsNCT07255872
What this trial is testing

BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Sichuan Baili Pharmaceutical Co., Ltd. 216
Not applicableNo Longer AvailableNCT05627466
What this trial is testing

US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
Gilead Sciences
Early research (Phase 1)Study completedNCT00710528
What this trial is testing

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Lymphoma, Non-Hodgkin (NHL)Acute Myeloid Leukemia (AML)+1 more
Gilead Sciences 192
Early research (Phase 1)Study completedNCT00351975
What this trial is testing

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Who this might be right for
Accelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)WithdrawnNCT04100330
What this trial is testing

Ficlatuzumab With HiDAC and HiDAC Alone in Adults With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
AVEO Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT04861207
What this trial is testing

Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes

Who this might be right for
Acute Myeloid Leukemia Myelodysplastic Syndromes
Maria Sklodowska-Curie National Research Institute of Oncology 40
Large-scale testing (Phase 3)Study completedNCT00003436
What this trial is testing

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Medical Research Council 2,000
Not applicableStudy completedNCT01005277
What this trial is testing

Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1Adult Acute Promyelocytic Leukemia With PML-RARA+6 more
Children's Oncology Group 2,000
Testing effectiveness (Phase 2)Ended earlyNCT03735875
What this trial is testing

Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationRecurrent Acute Myeloid LeukemiaRefractory Acute Leukemia
M.D. Anderson Cancer Center 8
Early research (Phase 1)Active Not RecruitingNCT04603001
What this trial is testing

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+1 more
Eli Lilly and Company 260
Testing effectiveness (Phase 2)UnknownNCT04284228
What this trial is testing

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
NexImmune Inc. 22
Early research (Phase 1)Looking for participantsNCT06651866
What this trial is testing

Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Xiamen University 18
Not applicableStudy completedNCT05972577
What this trial is testing

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more
Ohio State University Comprehensive Cancer Center 30
Next Page